Monitored COVID-19 vaccine humoral response in immunocompromised solid organ transplant recipients
- 2 February 2024
- journal article
- research article
- Published by Elsevier in Human Immunology
- Vol. 85 (2) , 110760
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- De novo posttransplant membranous nephropathy following BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipientAmerican Journal of Transplantation, 2023
- Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant RecipientsJAMA Cardiology, 2022
- COVID-19 vaccination in kidney transplant recipientsNature Reviews Nephrology, 2021
- Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancerCancer Cell, 2021
- Covid-19 vaccine trials: Ethnic diversity and immunogenicityVaccine, 2021
- Postvaccine Anti–SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant RecipientsKidney International Reports, 2021
- Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 VaccinationTransplantation, 2021
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionScience, 2021
- Sars-CoV-2 and black population: ACE2 as shield or blade?Infection, Genetics and Evolution, 2020
- COVID-19 in solid organ transplant recipients: Initial report from the US epicenterAmerican Journal of Transplantation, 2020